ES2110947T3 - Preparado de albumina y procedimiento para su preparacion. - Google Patents

Preparado de albumina y procedimiento para su preparacion.

Info

Publication number
ES2110947T3
ES2110947T3 ES89120186T ES89120186T ES2110947T3 ES 2110947 T3 ES2110947 T3 ES 2110947T3 ES 89120186 T ES89120186 T ES 89120186T ES 89120186 T ES89120186 T ES 89120186T ES 2110947 T3 ES2110947 T3 ES 2110947T3
Authority
ES
Spain
Prior art keywords
preparation
albumin
content
procedure
solution
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES89120186T
Other languages
English (en)
Inventor
Yasushi Matsuoka
Shinichirou Hase
Kazuo Takechi
Shinji Tomioka
Kazumasa Yokoyama
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Tanabe Pharma Corp
GC Biopharma Corp
Original Assignee
Green Cross Corp
Green Cross Corp Korea
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=26451019&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ES2110947(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Green Cross Corp, Green Cross Corp Korea filed Critical Green Cross Corp
Application granted granted Critical
Publication of ES2110947T3 publication Critical patent/ES2110947T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/76—Albumins
    • C07K14/765—Serum albumin, e.g. HSA
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2/00—Disinfection or sterilisation of materials or objects, in general; Accessories therefor
    • A61L2/02—Disinfection or sterilisation of materials or objects, in general; Accessories therefor using physical processes
    • A61L2/04—Heat
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2103/00—Materials or objects being the target of disinfection or sterilisation
    • A61L2103/05—Living organisms or biological materials
    • A61L2103/09—Blood or products thereof

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Zoology (AREA)
  • Biophysics (AREA)
  • Diabetes (AREA)
  • Toxicology (AREA)
  • Cardiology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biochemistry (AREA)
  • Hematology (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Immunology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)

Abstract

SE PRESENTA UNA PREPARACION DE ALBUMINA QUE TIENE UN CONTENIDO DE POLIMERO NO MAYOR QUE EL 3% EN BASE AL CONTENIDO DE ALBUMINA DE SUERO Y UN CONTENIDO DE ALFA-AGP DE NO MAS QUE UN LIMITE DETECTABLE EN BASE AL CONTENIDO DE ALBUMINA DE SUERO, DICHA PREPARACION SE OBTIENE SEPARANDO UN FACTOR DE FORMACION DE POLIMERO DE UNA SOLUCION ACUOSA DE ALBUMINA, POR EJEMPLO MEDIANTE SEPARACION DE INTERCAMBIO DE ION O CROMATOGRAFIA DE AFINIDAD, Y EXPONIENDO LA SOLUCION A UN TRATAMIENTO DE CALOR.
ES89120186T 1988-10-31 1989-10-31 Preparado de albumina y procedimiento para su preparacion. Expired - Lifetime ES2110947T3 (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP27708288 1988-10-31
JP11168189A JP3554796B2 (ja) 1988-10-31 1989-04-28 アルブミン製剤及びその製造方法

Publications (1)

Publication Number Publication Date
ES2110947T3 true ES2110947T3 (es) 1998-03-01

Family

ID=26451019

Family Applications (1)

Application Number Title Priority Date Filing Date
ES89120186T Expired - Lifetime ES2110947T3 (es) 1988-10-31 1989-10-31 Preparado de albumina y procedimiento para su preparacion.

Country Status (7)

Country Link
EP (1) EP0367220B1 (es)
JP (1) JP3554796B2 (es)
KR (1) KR100201195B1 (es)
AU (1) AU624436B2 (es)
CA (1) CA2001911A1 (es)
DE (1) DE68928527T2 (es)
ES (1) ES2110947T3 (es)

Families Citing this family (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH0768137B2 (ja) * 1989-06-15 1995-07-26 株式会社ミドリ十字 アルブミン製剤及びその製法
US5250662A (en) * 1989-10-05 1993-10-05 Alpha Therapeutic Corporation Albumin purification
CA2022165C (en) * 1989-10-05 1999-11-23 Chong E. Chang Albumin purification
JP2949846B2 (ja) * 1990-11-30 1999-09-20 吉富製薬株式会社 アルブミン製剤の保存方法
FR2672604B1 (fr) * 1991-02-07 1995-05-05 Pasteur Merieux Serums Vacc Procede pour isoler de l'albumine humaine a partir du surnageant iv, notamment iv-4, ou de la fraction v de cohn ou d'un surnageant ou fraction analogue.
FR2690444B1 (fr) * 1992-04-22 1995-07-13 Rucheton Marcel Procede de preparation d'une solution d'albumine plasmatique purifiee.
US5521287A (en) * 1992-05-20 1996-05-28 The Green Cross Corporation Recombinant human serum albumin, process for producing the same and pharmaceutical preparation containing the same
JPH07102148B2 (ja) * 1992-05-20 1995-11-08 株式会社ミドリ十字 遺伝子操作により得られるヒト血清アルブミンの製造方法、およびそれにより得られるヒト血清アルブミン含有組成物
US5440018A (en) * 1992-05-20 1995-08-08 The Green Cross Corporation Recombinant human serum albumin, process for producing the same and pharmaceutical preparation containing the same
US5728553A (en) * 1992-09-23 1998-03-17 Delta Biotechnology Limited High purity albumin and method of producing
JPH07126182A (ja) * 1993-10-27 1995-05-16 Green Cross Corp:The 組換えヒト血清アルブミン製剤の滅菌方法
AUPM388494A0 (en) * 1994-02-16 1994-03-10 Csl Limited Process for removing endotoxins
JP3702474B2 (ja) 1994-06-01 2005-10-05 三菱ウェルファーマ株式会社 血清アルブミン製剤の製造方法
GB9902000D0 (en) 1999-01-30 1999-03-17 Delta Biotechnology Ltd Process
JP4798832B2 (ja) * 2000-10-24 2011-10-19 一般財団法人化学及血清療法研究所 ヒト血清アルブミン多量体の除去方法
US7252799B2 (en) 2001-08-31 2007-08-07 Clearant, Inc. Methods for sterilizing preparations containing albumin
BR0316563A (pt) * 2002-11-25 2005-10-04 Octapharma Ag Fração de albumina derivada de plasma exaurido de prekallikrein
CA2524246C (en) 2003-04-09 2014-10-14 Juridical Foundation The Chemo-Sero-Therapeutic Research Institute Process for producing albumin preparations comprising virus-removing filtration
GB0423196D0 (en) 2004-10-19 2004-11-24 Nat Blood Authority Method
ES2294976B1 (es) * 2007-11-12 2008-12-16 Grifols, S.A. "procedimiento de obtencion de albumina humana de alta eficacia para su uso en terapia de detoxificacion".
US12629445B2 (en) 2020-03-20 2026-05-19 Bard Peripheral Vascular, Inc. Reactive hydrogel forming formulations and related methods, including methods of preparation
US11739166B2 (en) 2020-07-02 2023-08-29 Davol Inc. Reactive polysaccharide-based hemostatic agent
US12161777B2 (en) 2020-07-02 2024-12-10 Davol Inc. Flowable hemostatic suspension
WO2022146917A1 (en) 2020-12-28 2022-07-07 Davol Inc. Reactive dry powdered hemostatic materials comprising a protein and a multifunctionalized modified polyethylene glycol based crosslinking agent

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2537123A1 (de) * 1975-08-20 1977-03-03 New Zealand Inventions Dev Verfahren zur herstellung von albumin
SE405549B (sv) * 1975-10-09 1978-12-18 Pharmacia Fine Chemicals Ab Forfarande for isolering av albumin ur plasmaprodukter genom kromatografisk fraktionering
US4043997A (en) * 1976-05-28 1977-08-23 Cutter Laboratories, Inc. Method for isolating albumin using insoluble supports coupled to a dye
US4075197A (en) * 1976-09-20 1978-02-21 Monsanto Company Serum albumin production
US4228154A (en) * 1979-02-26 1980-10-14 Armour Pharmaceutical Company Purification of plasma albumin by ion exchange chromatography
FR2543448A1 (fr) * 1983-04-01 1984-10-05 Rhone Poulenc Spec Chim Procede de fractionnement du plasma
DE3344656A1 (de) * 1983-12-09 1985-06-13 Lentia GmbH Chem. u. pharm. Erzeugnisse - Industriebedarf, 8000 München Verfahren zur herstellung einer serumproteinloesung

Also Published As

Publication number Publication date
AU4394389A (en) 1990-05-03
EP0367220A2 (en) 1990-05-09
JP3554796B2 (ja) 2004-08-18
EP0367220B1 (en) 1998-01-07
DE68928527T2 (de) 1998-05-28
KR100201195B1 (ko) 1999-06-15
KR900005987A (ko) 1990-05-07
JPH02191226A (ja) 1990-07-27
EP0367220A3 (en) 1991-10-09
CA2001911A1 (en) 1990-04-30
DE68928527D1 (de) 1998-02-12
AU624436B2 (en) 1992-06-11

Similar Documents

Publication Publication Date Title
KR950700728A (ko) 약제형 및 그밖의 다른 복용형(Pharmaceutical and other dosage forms)
DK0776209T3 (da) Polynukleinsyrer og proteiner fra et porcin reproduktiv og respiratorisk syndrom-virus og anvendelser deraf
EP0367220A3 (en) Albumin preparation and process for preparing the same
DK0487615T3 (da) Ferritin-analoger
DK0424028T3 (da) S(+)-ibuprofen-L-aminosyre og S(+)-ibuprofen-D-aminosyre som et forbedret smertestillende middel med fremskyndet indtrædelse
NO922953D0 (no) Rekombinant fremstilt blodfaktorer og fremgangsmaate for ekspresjon av blodfaktorene, samt vacciniavirusrekombinanter
PT94226A (pt) Processo de preparacao de 1,2-dioxetanos que produzem quimioluminescencia por activacao dupla
KR890015742A (ko) 이병치료용 국소 제제
ES519944A0 (es) Procedimiento para la preparacion de proteinas succiniladas que contienen hierro.
ES2021411B3 (es) Proceso para la preparacion de (2,2) paraciclofano.
ES2148355T3 (es) Procedimiento para la preparacion de nevirapina.
MX9201216A (es) Procedimiento para la fabricacion de 2-cloro-1,1,1,2-tetra fluoro etano y penta fluoro etano.
FR2522010B1 (fr) Procede de reduction de la teneur en cyclopentadiene de courants gazeux d'hydrocarbures, notamment d'isoprene
ES2061690T3 (es) Proceso para producir resina de poliaminobisimida.
DE69028561D1 (de) Immunoassay zum Nachweis von Antikörpern gegen HIV
ES2046437T3 (es) Procedimiento para la separacion de cobre de unas soluciones acuosas de reaccion basica.
KR910013463A (ko) 반도체 소자의 개구형성방법
DE3785935D1 (de) Unkrautvertilgende zubereitungen vom glyphosattyp und vom phenoxybenzoesaeuretyp.
ES2089091T3 (es) Complejos que contienen acidos s(+)-fenilalcanoicos y acidos alfa-hidroalcanoicos.
KR880012237A (ko) 트롬빈 제제의 제조방법
ES2051953T3 (es) Derivados isomeros de trimetilbiciclo(4,3,0)nonano.
KR890000904A (ko) 렌즈
NO894037L (no) Fremgangsmaate for fremstilling av nye 2-metoksykarbonyl-substituerte n,n'-di(trimetoksybenzoyl) piperaziner.
SE8904232D0 (sv) Method of separation of furural from diluted aqueous solutions
KR890011615A (ko) 탈취제

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 367220

Country of ref document: ES